Therapy for Stage IV Non–Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2025.1
Abstract
Living guidelines are developed for selected topic areas with rapidly evolving evidence that drives frequent change in recommended clinical practice. Living guidelines are updated on a regular schedule by a standing expert panel that systematically reviews the health literature on a continuous basis, as described in the ASCO Guidelines Methodology Manual . ASCO Living Guidelines follow the ASCO Conflict of Interest Policy Implementation for Clinical Practice Guidelines . Living Guidelines and updates are not intended to substitute for independent professional judgment of the treating clinician and do not account for individual variation among patients. See appendix for disclaimers and other important information ( Appendix 1 and Appendix 2 ). Updates are published regularly and can be found at https://ascopubs.org/nsclc-non-da-living-guideline .
Article Details
Journal Info
Journal of Clinical Oncology
Lippincott Williams & Wilkins
Authors (11)
Dwight H. Owen
Balazs Halmos
Sonam Puri
Angel Qin
University of Michigan Health System, Ann Arbor, MI
Nofisat Ismaila
American Society of Clinical Oncology (ASCO), Alexandria, VA, US
Fawzi Abu Rous
Henry Ford Hospital, Detroit, MI
Krishna Alluri
Texas Oncology, San Antonio, TX
Janet Freeman-Daily
The ROS1ders, Seattle, WA
Narinder Malhotra
Yolanda G. Barco Cancer Institute, Meadville, PA
Kristen Ashley Marrone
John Hopkins Medical Center, Baltimore, MD, US
Lyudmila Bazhenova
University of California, San Diego, San Diego, CA, US